NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Net after R&D expenses. Perhaps some patients are getting a subsidy as the firm have further "real world" research they are doing while administering the vaccine? Maybe some of these patients are being used to validate Flaskworks?

As much as I thought we would see a large revenue increase under Specials that isn't the case. Though that shouldn't be a concern as the firm are funded through approvals.

Sawston has manufacturing capacity for 12K patients a year. Once we see MHRA approval this whole distraction will seem quite irrelevant!